rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
13
|
pubmed:dateCreated |
2002-6-28
|
pubmed:abstractText |
Barrett's esophagus (BE), a precancerous condition for Barrett's adenocarcinoma, is classically characterized by flames of salmon-colored mucosa extending into normal pale esophageal mucosa. This flaming is thought to be a consequence of continuous erosis of mucosa caused by chronic reflux. Another characteristic feature of Barrett's adenocarcinoma patients is the frequent development of lymph node metastases. We addressed whether onset of angiogenesis occurs in BE and if the lymphatic system might provide a route for Barrett's adenocarcinoma cells to infiltrate regular lymph nodes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vascular Endothelial...,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2971-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12089227-Adenocarcinoma,
pubmed-meshheading:12089227-Barrett Esophagus,
pubmed-meshheading:12089227-Disease Progression,
pubmed-meshheading:12089227-Endothelial Growth Factors,
pubmed-meshheading:12089227-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:12089227-Humans,
pubmed-meshheading:12089227-Immunohistochemistry,
pubmed-meshheading:12089227-Lymphatic System,
pubmed-meshheading:12089227-Lymphokines,
pubmed-meshheading:12089227-Matrix Metalloproteinase 2,
pubmed-meshheading:12089227-Matrix Metalloproteinase 9,
pubmed-meshheading:12089227-Neovascularization, Pathologic,
pubmed-meshheading:12089227-Receptor Protein-Tyrosine Kinases,
pubmed-meshheading:12089227-Receptors, Growth Factor,
pubmed-meshheading:12089227-Receptors, Vascular Endothelial Growth Factor,
pubmed-meshheading:12089227-Vascular Endothelial Growth Factor A,
pubmed-meshheading:12089227-Vascular Endothelial Growth Factors
|
pubmed:year |
2002
|
pubmed:articleTitle |
Incipient angiogenesis in Barrett's epithelium and lymphangiogenesis in Barrett's adenocarcinoma.
|
pubmed:affiliation |
Cellular Signalling Group, Division of Biochemistry, Department of Biosciences, Viikki BioCenter, University of Helsinki, Finland. merja.auvinen@astrazeneca.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|